Search

Search Constraints

You searched for: Author/Creator Mennitto, Alessia

Search Results

1. Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. (July 2021)

2. Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). Issue 1 (2nd January 2022)

5. Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma. Issue 6 (December 2021)

6. Everolimus treatment for neuroendocrine tumors: latest results and clinical potential. (March 2017)

7. GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study. Issue 1 (December 2016)

8. Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes. (August 2020)

9. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. Issue 2 (15th October 2020)

10. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists. Issue 2 (15th October 2020)